Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.
- Tsuneki, H. (講演者)
活動: 講演またはプレゼンテーション › 研究発表